Achillion Pharma (NASDAQ: ACHN) gained Friday morning following an update on ACH-3102 with Sovaldi for HCV treatment. Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE